NOV 02, 2018 11:52 AM PDT

Natural Molecule Enables Obese Mice to Shed Weight

WRITTEN BY: Carmen Leitch

A molecule that has been a focus of cancer research has been found to be a significant regulator of metabolism. Scientists at Georgetown University studied the effect of this molecule, FGFBP3, or BP3 for short, in a mouse model of obesity. They found that when they expressed the BP3 protein in the obese mice, it induced a pronounced reduction in fat mass, even though those mice consume food constantly.

Image credit: Pxhere

Obesity impacts tens of millions of people globally, and is to blame for a variety of different medical problems like insulin resistance and hypertension. This research, which has been published in the journal Scientific Reports, may open up new therapeutic avenues for metabolic disorders like fatty liver disease or type 2 diabetes.

"We found that eight BP3 treatments over 18 days was enough to reduce the fat in obese mice by over a third," said the senior investigator of the research, Anton Wellstein, MD, Ph.D., a professor of oncology and pharmacology at Georgetown Lombardi Comprehensive Cancer Center.

Those treatments also acted to lessen dysfunction related to obesity in the mouse model; it lowered excessive blood sugar and reduced the fat in their livers. The investigators did not identify any negative side effects either. The researchers note that this is a natural protein, not a synthetic drug, and clinical trials of a recombinant form of BP3 may begin soon.

BP3 is a member of the fibroblast growth factor (FGF) family of binding proteins (BP), giving it the FGFBP3 name. FGFs can be found in a huge number of different organisms, from worms to humans. They play parts in many different and important biological processes, like the control of cell growth, injury response, and wound repair. Some FGFs can act as hormones.

BP1, 2, and 3 accompany FGF proteins, as 'chaperones' that move them around the body. Wellstein has been interested in BP1 gene for some time because it is expressed at higher levels in different cancers. That suggested that some cancerous growth may be connected to an excess of FGFs. Recently, the Wellstein lab has begun to investigate the exact function of BP3.

They have determined that BP3 can chaperone three FGF proteins, called 19, 21, and 23, which are involved in metabolic regulation. Sugar and fat storage is influenced by FGF19 and FGF 21, while FGF23 has a role in the metabolism of phosphate.

"We found that BP3 exerts a striking contribution to metabolic control," Wellstein said. "When you have more BP3 chaperone available, FGF19 and FGF21 effect is increased through the increase of their signaling. That makes BP3 a strong driver of carbohydrate and lipid metabolism. It's like having a lot more taxis available in New York City to pick up all the people who need a ride."

"With metabolism revved up, sugar in the blood, and fat processed in the liver are used for energy and is not stored," Wellstein continued. "And warehouses of fat are tapped as well. For example, the job of FGF21 is to control break down of fat, whether it is stored or just eaten."

More research will be necessary to confirm that BP3 is an effective way to treat human metabolic syndromes disorders, the researchers acknowledged.


Sources: AAAS/Eurekalert! Via Georgetown University, Scientific Reports

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 13, 2020
Cell & Molecular Biology
RNA Found on the Surface of Human Cells
SEP 13, 2020
RNA Found on the Surface of Human Cells
The surface of a cell carries many features to help it carry out its functions, communicate with other cells, gather inf ...
OCT 09, 2020
Genetics & Genomics
Using CRISPR to Destroy Cancer Cells
OCT 09, 2020
Using CRISPR to Destroy Cancer Cells
Researchers have developed a way to selectively target certain cancer cells with CRISPR.
OCT 29, 2020
Microbiology
Metabolomics and the Microbiome
OCT 29, 2020
Metabolomics and the Microbiome
The average person contains large variations in bacteria from the mouth, the skin, sweat, and in the stomach and intesti ...
OCT 29, 2020
Genetics & Genomics
Severe Genomic Damage in Human Embryos Treated With CRISPR
OCT 29, 2020
Severe Genomic Damage in Human Embryos Treated With CRISPR
The CRISPR-Cas9 genomic editing system holds great promise for treating genetic errors that cause human disease. But we ...
NOV 19, 2020
Cardiology
Examining a Possible Link Between Atherosclerosis and Inflammation
NOV 19, 2020
Examining a Possible Link Between Atherosclerosis and Inflammation
The immune system’s primary duty is to protect the body from dangerous invaders. Many don’t know that it als ...
NOV 25, 2020
Cell & Molecular Biology
Antibacterial Soap Ingredient May Increase Risk of Liver Disease
NOV 25, 2020
Antibacterial Soap Ingredient May Increase Risk of Liver Disease
The triclosan once commonly added to soap was banned by the FDA a few years ago, but it can still be found in some water ...
Loading Comments...